Reducing the risk of contamination by bioquelling
The life sciences market has many challenges in both the R&D pipeline and manufacturing, maintaining aseptic conditions or reducing bioburden often the case. In particular, decontaminating to achieve these goals is important in key application areas such as cell & gene therapy, sterility testing, compounding and decontaminating equipment or environments.
Whether you are involved in academic research, the pharma or biopharma industry, or working in a pharmacy environment, decontaminating with Bioquell will give you faster, more efficient bio-decontamination.
Bioquell has a long history in the Life Sciences and has applications across a range of markets. Whether you work in fundamental research or pharmaceutical production, it is likely that you or one of your counterparts uses a Bioquell process for improved bio-security to mitigate potential issues or for maintaining a higher level of uptime to enhance productivity. Whether you are regulated to cGMP manufacturing, protecting employees from high risk pathogens or testing the sterility of products for batch release, Bioquell can provide an environment in which your methods and applications are secure. We have characterised our customer markets as per the links below, read on for more information on how we apply decontamination in these areas: